President Donald Trump has nominated Dr. Casey Means, a physician and health tech entrepreneur, as the next U.S. Surgeon General. The announcement, made Wednesday, highlights Means' alignment with Health Secretary Robert F. Kennedy Jr.’s "Make America Healthy Again" initiative.
Dr. Means, 37, co-founded the health technology company Levels, which uses data from continuous glucose monitors to help users understand how their food choices affect metabolic health. She is a strong advocate for using personalized data to drive healthier lifestyles and is widely seen as a rising voice in the preventive health and biohacking movement.
Her brother, Calley Means, was recently appointed as a White House adviser, focusing on food policy reform and addressing corporate influence on national health trends. Together, the Means siblings have been vocal supporters of reshaping American health through nutrition-focused and tech-driven approaches.
Dr. Means will replace Trump’s previous nominee, Dr. Janette Nesheiwat, who the president announced will now serve in a different senior role within the Department of Health and Human Services alongside Secretary Kennedy.
As Surgeon General, Dr. Means would become the nation’s leading spokesperson on public health, responsible for delivering science-based guidance on disease prevention, wellness, and reducing chronic illness. Her nomination is expected to energize health reform advocates who support lifestyle medicine and digital health innovation.
Trump’s pick signals a continued shift toward preventive care and a broader embrace of alternative health strategies that prioritize nutrition, metabolic awareness, and data-driven wellness tools. The nomination must still be confirmed by the Senate.


Trump to Visit China for Key U.S.-China Summit With Xi Jinping
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Rubio Discusses Iran Crisis and Strait of Hormuz Disruptions With UK and Australia
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
US, Japan Reaffirm Strong Currency Coordination Amid Yen Volatility
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Trump Rejects Iran Proposal as Strait of Hormuz Crisis Pushes Oil Prices Higher
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Trump Weighs Renewed Military Action Against Iran Amid Strait of Hormuz Crisis
Qatar Condemns Drone Strike as Iran Conflict Threatens Gulf Shipping and Global Markets
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Malaysia Unveils Energy Security Plan Amid Iran Conflict and Rising Oil Costs 



